Limited seating available
7th
Annual Conference for Asian New Drug Development in Japan – last chance to register.
Day 1 Highlights The
conference, to be held at Nakano Sunplaza in Tokyo from April 15-16, will
provide a forum for exchange of opinions among the regulatory agencies in East
Asia, including the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan,
the Korea Food and Drug Administration (KFDA) and the Center for Drug Evaluation
(CDE) in Taiwan.
Constructive discussions will be held on how to
overcome the hurdles still remaining in new drug development using case studies
of drugs that obtained approvals in Japan based upon East Asia multiregional
clinical trial (MRCT) data.
Day 2 Highlights
Day two of the conference starts with a session that will discuss one of the
key factors influencing development strategy –Market Access. The attendees will
particularly focus on differences in practice among countries.
An
interactive workshop will follow, lead by instructors who have day-to-day
experience in new drug development in East Asia. The workshop will be valuable
to participants who are planning to file IND/NDA in China, Korea, and Taiwan,
who are interested in regulations and clinical development operations in East
Asia, or who are working on the front line of clinical development.
|
|
Upcoming events
|
|
Register online or download
an application form and forward to:
DIA Japan, Nisso 22 Building, 7F,
1-11-10 Azabudai, Minato-ku,
Tokyo 106-0041 Japan
Tel:
+81-3-5575-2130
Fax: +81-3-3583-1200
DIAJapan@diajapan.org
Tabletop exhibit opportunity
Please contact DIA Japan for
details about tabletop exhibits.
Tel: +81-3-5575-2130
Fax:
+81-3-3583-1200
Email: DIAJapan@diajapan.org
|
|
|
|
|
No comments:
Post a Comment